URYPAB traded at 0.0249329 this Monday September 8th, decreasing 0.0001706 or 0.68 percent since the previous trading session. Looking back, over the last four weeks, URYPAB lost 0.25 percent. Over the last 12 months, its price rose by 0.61 percent. Looking ahead, we forecast URYPAB to be priced at 0.0248557 by the end of this quarter and at 0.0247210 in one year, according to Trading Economics global macro models projections and analysts expectations.